VTU Engineering Belgium

Blarenberglaan 4

2800 Mechelen

BE

VTU Engineering Belgium

Foundation date

09/03/2022

Sector

#Supplier & Engineering

Subsector

At VTU Group we design and deliver facilities and manufacturing systems for clients in the life sciences, pharmaceutical, biotechnology, chemicals, ingredients, food and nutrition and related industries. 
 
Our three areas of expertise are: 

  • Life Sciences 

  • Digitalization 

  • Transformation to sustainability 


Projects range from expert advice, asset optimizations and smaller modifications to complete new facilities. The unique combination of our in-house expertise allows developers of innovative medicinal products to have a one stop partner from the late clinical development phase till the operational support for manufacturing at commercial scale. 

Our services include: 

  • Manufacturing Science & Technology (MSAT) as a service 

    • Technology transfers, process characterisation, process validation, cleaning validation, control strategy development, Continued Process Verification (CPV or OPV) 

    • Analytic studies in the scope of process transfers and process validations (analytic transfer, stability studies, comparability, bio-similarity, method validation) 

  • Front end design & Engineering 

    • Process Engineering 

    • Building Services including HVAC and Cleanroom Technology 

    • Automation & Digitalization 

    • Piping & Mechanical Engineering 

    • Green Engineering including design sustainability assessments 

  • Capex Project delivery: EPCMv 

    • Procurement 

    • Construction Management 

    • Commissioning, Qualification & Validation (CQV) 

  • Consulting and advice 

    • Capex: Site development strategy, PMO analytics & reporting 

    • Opex: Site & Line Excellence – Business Process Optimization 

    • Quality Excellence: Lab excellence, Risk management, Inspection readiness 

  • GMP and Quality related services 

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024